Aardvark Therapeutics, Inc. Common Stock (AARD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aardvark Therapeutics, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -4.97x | -15.08x | -42.45x | -22.56x |
| P/B Ratio | 2.69x | -5.68x | -8.79x | -10.96x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 10.61x | 15.05x | 7.50x | 27.72x |
| Quick Ratio | 10.61x | 15.05x | 7.50x | 27.72x |
| Leverage | ||||
| Debt/Equity | 0.00x | -0.01x | -0.00x | -0.01x |
YoY = year-over-year change. Source: FMP..